LEGN
Legend Biotech
$19.27
−$2.95 (−13.28%)Jul 27, 2026
Key metrics
The numbers that frame LEGN today
- Market cap
- $3.58B
- P/E (TTM)
- -14.3
- EV / FCF
- -31.1
- Gross margin
- 55%
- EV / Sales
- 2.8
- ROIC
- -31.3%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $16.24
- 52wk High
- $44.17
Growth
Revenue and earnings trend for LEGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LEGN
Is Legend Biotech a good buy?
Yes. Legend Biotech has strong quality and mixed momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Legend Biotech is selling at a high price, which cuts against the buy case.
What is the market capitalization of LEGN?
Legend Biotech's market capitalization is $3.58B.
What is the P/E ratio for LEGN stock?
Legend Biotech's current P/E ratio is -14.3.
What is the 52-week high for LEGN stock?
The 52-week high for Legend Biotech is $44.17. The current close of $19.27 is 56.4% below that high.
What is the 52-week low for LEGN stock?
The 52-week low for Legend Biotech is $16.24. The current close of $19.27 is 18.7% above that low.
Does LEGN stock pay dividends?
Legend Biotech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LEGN?
Legend Biotech's Debt / Equity ratio is 0.4.